-
Why does the delta mutant strain spread so fast?
Time of Update: 2021-08-26
Shanghai epidemic prevention and control leading group members of the Group of Fudan University Shanghai Medical College, Vice President Wu Fan: Although the vaccine is not hundred percent block the infection, but it can effectively reduce the proportion of severe, this point is very important .
-
The highest rate of decrease was 71.30%, and the prices of 591 consumables such as Medtronic and Dabo were reduced
Time of Update: 2021-08-26
On August 16, the Liaoning Provincial Drug and Medical Consumables Centralized Purchasing Network issued the "Notice on the Result of Active Price Reduction of 122 Consumables Including Drug Eluting
-
National Health Commission: The risk of a large-scale epidemic nationwide is small
Time of Update: 2021-08-26
He Qinghua, the first-level inspector of the CDC of the National Health Commission, said at the meeting that The risk of the epidemic is generally controllable, and the risk of a large-scale epidemic at the national level is relatively small .
-
On the 16th, 42 new cases of new crown were diagnosed, including 6 cases in the local area
Time of Update: 2021-08-26
As of 24:00 on August 16, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1928 confirmed cases (including 67 severe cases), 87,908 cured and discharged cases, and 4,636 deaths.
-
A suspected case of skin anthrax in Wenshui, Shanxi has been treated in isolation
Time of Update: 2021-08-26
At present, the local area has isolated and treated 5 cases in Wenshui County, disinfected their place of activity and excrement, conducted investigation and control of contacts, carried out active case searches in Baoxian Village, and asked village doctors to strengthen surveillance.
-
The standard for pharmaceutical packaging materials is about to be listed in the Chinese Pharmacopoeia!
Time of Update: 2021-08-26
Yang Zhaopeng, Deputy Secretary-General of the Commission emphasized that our Commission should accelerate the development of the "Chinese Pharmacopoeia" standard system for pharmaceutical packaging materials.
Yang Zhaopeng, deputy secretary-general of the Pharmacopoeia Commission, emphasized that the Commission should accelerate the construction of the "Chinese Pharmacopoeia" standard system for pharmaceutical packaging materials.
-
The State Food and Drug Administration issued a notice that 18 batches of drugs did not meet the requirements
Time of Update: 2021-08-26
After inspection by Hubei Provincial Institute of Drug Supervision and Inspection, a batch of Atractylodes japonicus (fried atractylodes with bran) produced by Anhui Wukeng Chinese Medicine Decoction Pieces Co.
-
The lambda strain swept South America, here is what you want to know
Time of Update: 2021-08-26
The Australian "Dialogue" magazine reported that preliminary research data on lambda showed that lambda is more contagious, and it is more likely to infect human cells than the original new coronavirus and variants of alpha and gamma .
-
Health Commission: Newly diagnosed 81 new cases of new crown on the 11th, 61 local cases
Time of Update: 2021-08-26
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on August 11 The latest situation of the novel coronavirus pneumonia epidemic situation as of 24:00 on A
-
The 2020 drug review report is released!
Time of Update: 2021-08-17
The Center for Drug Evaluation has completed 8606 registration applications requiring technical review, and 1561 new drug clinical trial (IND) applications have been reviewed, an increase of 55.
-
Puli Pharmaceuticals: Levetiracetam concentrated solution for injection has been approved for marketing in Thailand
Time of Update: 2021-08-17
On June 21, Puli Pharmaceuticals announced that the concentrated solution of levetiracetam for injection has been approved by the Food and Drug Administration of Thailand . Levetiracetam injection co
-
The licensed pharmacist supervision app is here
Time of Update: 2021-08-17
According to Jingdezhen's online news, in September 2020, Jingdezhen City launched a pilot program for a licensed pharmacist management system, which integrates various functions such as continuing education, academic qualification improvement, and market supervision, and can implement GPS positioning and face recognition attendance for pharmacists .
-
Jianyou shares: Daptomycin for injection has been approved by the US FDA for drug registration
Time of Update: 2021-08-16
On June 30, Jianyou shares announced that its subsidiary Hong Kong Jianyou recently received daptomycin for injection, 500mg/bottle (ANDA number: 213623), 350mg/bottle (ANDA number: 213786) issued by the US Food and Drug Administration.
Letter of approval .
-
Takeda is sued for delaying the listing of Amitiza's generic drug
Time of Update: 2021-08-16
CompilationFan DongdongA few days ago, foreign media reported that according to the latest class-action lawsuit, the patent agreement reached between Takeda and Endo’s Par Pharmaceuticals delayed the launch of Takeda’s constipation drug Amitiza, suspected of violating the antitrust law, causing The patient's medical expenses exceeded hundreds of millions of yuan .
-
The second half of 2021: medical representatives are difficult
Time of Update: 2021-08-16
Similar to the impact of national centralized procurement, for medical representatives, as local supplementary products are gradually removed from medical insurance, they will also face the problem of transformation or job transfer .
-
Subcutaneous injection of PD-L1 antibody envolimab was again approved as an orphan drug by the U.S. FDA
Time of Update: 2021-08-16
Corning Jereh announced that the company's self-developed recombinant humanized PD-L1 single domain antibody envolimab injection has been granted orphan drug designation by the US Food and Drug Administration for the treatment of soft tissue sarcoma .
-
Jiangsu Wuzhong YS001 Capsule was approved to carry out clinical trials for the treatment of advanced malignant solid tumors
Time of Update: 2021-08-16
YS001 capsule is a PI3K/mTOR dual-target inhibitor independently developed by Suzhou Zerun New Drug R&D Co.
The target indications for its research and development are advanced malignant solid tumors such as breast cancer, kidney cancer, gastric cancer, and ovarian cancer .
-
Reached the main clinical endpoint!
Time of Update: 2021-08-16
Note: The original text has been deletedReference materials:[1] Jun Shengtai will present the results of the Phase II clinical trial of HTD1801 in the treatment of primary sclerosing cholangitis.
-
What is the largest increase in Hengrui, Shanghai Pharmaceuticals, CSPC, and Yangtze River's impact on the top 20 global pharmaceutical companies?
Time of Update: 2021-08-16
Generally speaking, there are two paths: after the innovative drug is listed in the mainstream market, it becomes a blockbuster with annual revenue of over US$1 billion; or it "subverts" Hengrui's past development genes and completes a major acquisition .
-
Jazz oncology drug Rylaze is approved by FDA for treatment of ALL and LBL
Time of Update: 2021-08-16
CompileriverA few days ago, Rylaze, an oncology drug from Jazz Pharmaceuticals, was approved by the US FDA for the treatment of pediatric patients 1 month and older who are allergic to E.
